Low-intensity focused ultrasound (LIFU), a non-invasive targeted brain stimulation technology, has shown promise for therapeutic applications in Alzheimer's disease (AD) patients. Despite its potential, the implications of repeated LIFU neuromodulation in AD patients remain to be investigated.
Objective
This pilot study evaluated the safety and potential to improve cognition and functional connectivity following repeated LIFU treatment in AD patients.
Methods
Ten early-stage AD patients underwent six sessions of neuronavigation-guided LIFU targeting the left dorsolateral prefrontal cortex (DLPFC) within 2–3 weeks, alongside ongoing standard pharmacotherapy. Neuropsychological assessments and resting-state functional magnetic resonance imaging were performed at baseline and eight weeks post-treatment.
Results
Memory performance (p = 0.02) and functional connectivity between the left DLPFC and both the left perirhinal cortex and left dorsomedial prefrontal cortex (corrected p < 0.05) significantly improved from baseline. Additionally, enhancements in memory performance were positively correlated with increases in functional connectivity of the left DLPFC with the left perirhinal cortex (Kendall's tau = 0.56, p = 0.03). No adverse events were reported during the LIFU treatments or at the subsequent follow-up.
Conclusions
LIFU may have the therapeutic potential to enhance both brain network connectivity and memory functions in AD patients. Our results provide a basis for further research, including randomized sham-controlled trials and optimization of stimulation protocols, on LIFU as a supplementary or alternative treatment option for AD.
Trial registration
Clinical Research Information Service, KCT0008169, Registered on 10 February 2023
TolarMAbushakraSSabbaghM. The path forward in Alzheimer's disease therapeutics: reevaluating the amyloid cascade hypothesis. Alzheimers Dement2020; 16: 1553–1560.
2.
Conti FilhoCELossLBMarcolongo-PereiraC, et al.Advances in Alzheimer's disease's pharmacological treatment. Front Pharmacol2023; 14: 1101452.
3.
LiuKYHowardR. Can we learn lessons from the FDA's approval of aducanumab?Nat Rev Neurol2021; 17: 715–722.
4.
DayanECensorNBuchER, et al.Noninvasive brain stimulation: from physiology to network dynamics and back. Nat Neurosci2013; 16: 838–844.
5.
SiddiqiSHKhosravaniSRolstonJD, et al.The future of brain circuit-targeted therapeutics. Neuropsychopharmacology2024; 49: 179–188.
6.
AntalAAlekseichukIBiksonM, et al.Low intensity transcranial electric stimulation: safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol2017; 128: 1774–1809.
7.
RossiSAntalABestmannS, et al.Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert guidelines. Clin Neurophysiol2021; 132: 269–306.
8.
ImJJJeongHBiksonM, et al.Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer's disease. Brain Stimul2019; 12: 1222–1228.
9.
YanYTianMWangT, et al.Transcranial magnetic stimulation effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. Front Neurol2023; 14: 1209205.
10.
YunKSongIUChungYA. Changes in cerebral glucose metabolism after 3 weeks of noninvasive electrical stimulation of mild cognitive impairment patients. Alzheimers Res Ther2016; 8: 49.
11.
HampsteadBMSathianKBiksonM, et al.Combined mnemonic strategy training and high-definition transcranial direct current stimulation for memory deficits in mild cognitive impairment. Alzheimers Dement (N Y)2017; 3: 459–470.
LeeKParkTYLeeW, et al.A review of functional neuromodulation in humans using low-intensity transcranial focused ultrasound. Biomed Eng Lett2024; 14: 407–438.
14.
LeeWWeisholtzDSStrangmanGE, et al.Safety review and perspectives of transcranial focused ultrasound brain stimulation. Brain Neurorehabil2021; 14: e4.
15.
FomenkoANeudorferCDallapiazzaRF, et al.Low-intensity ultrasound neuromodulation: an overview of mechanisms and emerging human applications. Brain Stimul2018; 11: 1209–1217.
16.
YuKNiuXKrook-MagnusonE, et al.Intrinsic functional neuron-type selectivity of transcranial focused ultrasound neuromodulation. Nat Commun2021; 12: 2519.
17.
YooSMittelsteinDRHurtRC, et al.Focused ultrasound excites cortical neurons via mechanosensitive calcium accumulation and ion channel amplification. Nat Commun2022; 13: 493.
18.
MengYHynynenKLipsmanN. Applications of focused ultrasound in the brain: from thermoablation to drug delivery. Nat Rev Neurol2021; 17: 7–22.
19.
LipsmanNMengYBethuneAJ, et al.Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound. Nat Commun2018; 9: 2336.
20.
D'HaesePFRanjanMSongA, et al.beta-amyloid plaque reduction in the hippocampus after focused ultrasound-induced blood-brain barrier opening in Alzheimer's disease. Front Hum Neurosci2020; 14: 593672.
21.
RezaiARRanjanMD'HaesePF, et al.Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound. Proc Natl Acad Sci U S A2020; 117: 9180–9182.
22.
MehtaRICarpenterJSMehtaRI, et al.Blood-brain barrier opening with MRI-guided focused ultrasound elicits meningeal venous permeability in humans with early Alzheimer disease. Radiology2021; 298: 654–662.
23.
JeongHSongIUChungYA, et al.Short-term efficacy of transcranial focused ultrasound to the hippocampus in Alzheimer's disease: A preliminary study. J Pers Med2022; 12: 250.
24.
DuboisBFeldmanHHJacovaC, et al.Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol2007; 6: 734–746.
25.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.
MorrisJCHeymanAMohsRC, et al.The consortium to establish a registry for Alzheimer's disease (CERAD). part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology1989; 39: 1159–1165.
28.
KangYJahngSNaDL. Seoul neuropsychological screening battery-II (SNSB-II). Seoul: Human Brain Research & Consulting Co., 2012.
29.
HuMNitscheMALvY, et al.The effects of repetitive transcranial magnetic and transcranial direct current stimulation on memory functions in older adults with mild cognitive impairment: a systematic review and meta-analysis. Front Hum Neurosci2024; 18: 1436448.
30.
FernandesSMMendesAJRodriguesPFS, et al.Efficacy and safety of repetitive transcranial magnetic stimulation and transcranial direct current stimulation in memory deficits in patients with Alzheimer's disease: meta-analysis and systematic review. Int J Clin Health Psychol2024; 24: 100452.
31.
RabkinJGMarkowitzJSOcepek-WeliksonK, et al.General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. J Clin Psychopharmacol1992; 12: 3–10.
32.
FitzpatrickJMWestJB. The distribution of target registration error in rigid-body point-based registration. IEEE Trans Med Imaging2001; 20: 917–927.
33.
LeeWKimHJungY, et al.Image-guided transcranial focused ultrasound stimulates human primary somatosensory cortex. Sci Rep2015; 5: 8743.
34.
OhJRyuJSKimJ, et al.Effect of low-intensity transcranial focused ultrasound stimulation in patients with major depressive disorder: a randomized, double-blind, sham-controlled clinical trial. Psychiatry Investig2024; 21: 885–896.
35.
KimHLeeSDChiuA, et al.Estimation of the spatial profile of neuromodulation and the temporal latency in motor responses induced by focused ultrasound brain stimulation. Neuroreport2014; 25: 475–479.
36.
AndradeSMde Oliveira MarquesCCde LucenaLC, et al.Effect of transcranial direct current stimulation and transcranial magnetic stimulation on the cognitive function of individuals with Alzheimer's disease: a systematic review with meta-analysis and meta-regression. Neurol Res2024; 46: 453–465.
37.
SanchesCStengelCGodardJ, et al.Past, present, and future of non-invasive brain stimulation approaches to treat cognitive impairment in neurodegenerative diseases: time for a comprehensive critical review. Front Aging Neurosci2020; 12: 578339.
38.
Whitfield-GabrieliSNieto-CastanonA. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect2012; 2: 125–141.
39.
PowerJDMitraALaumannTO, et al.Methods to detect, characterize, and remove motion artifact in resting state fMRI. Neuroimage2014; 84: 320–341.
40.
BehzadiYRestomKLiauJ, et al.A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage2007; 37: 90–101.
41.
YaakubSNWhiteTARobertsJ, et al.Transcranial focused ultrasound-mediated neurochemical and functional connectivity changes in deep cortical regions in humans. Nat Commun2023; 14: 5318.
42.
FolloniDVerhagenLMarsRB, et al.Manipulation of subcortical and deep cortical activity in the primate brain using transcranial focused ultrasound stimulation. Neuron2019; 101: 1109–1116e1105.
43.
SanguinettiJLHameroffSSmithEE, et al.Transcranial focused ultrasound to the right prefrontal cortex improves mood and alters functional connectivity in humans. Front Hum Neurosci2020; 14: 52.
44.
CainJAVisaganSJohnsonMA, et al.Real time and delayed effects of subcortical low intensity focused ultrasound. Sci Rep2021; 11: 6100.
45.
AchimAMLepageM. Dorsolateral prefrontal cortex involvement in memory post-retrieval monitoring revealed in both item and associative recognition tests. Neuroimage2005; 24: 1113–1121.
46.
SuzukiWAAmaralDG. Perirhinal and parahippocampal cortices of the macaque monkey: cortical afferents. J Comp Neurol1994; 350: 497–533.
47.
BaxterMG. Involvement of medial temporal lobe structures in memory and perception. Neuron2009; 61: 667–677.
48.
SuzukiWANayaY. The perirhinal cortex. Annu Rev Neurosci2014; 37: 39–53.
49.
DavachiLMitchellJPWagnerAD. Multiple routes to memory: distinct medial temporal lobe processes build item and source memories. Proc Natl Acad Sci U S A2003; 100: 2157–2162.
50.
KaufmanSKDel TrediciKThomasTL, et al.Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART. Acta Neuropathol2018; 136: 57–67.
51.
XieLDasSRWisseLEM, et al.Early tau burden correlates with higher rate of atrophy in transentorhinal cortex. J Alzheimers Dis2018; 62: 85–92.
52.
RaniNAlmKHCorona-LongCA, et al.Tau PET burden in Brodmann areas 35 and 36 is associated with individual differences in cognition in non-demented older adults. Front Aging Neurosci2023; 15: 1272946.
53.
MaassABerronDHarrisonTM, et al.Alzheimer's pathology targets distinct memory networks in the ageing brain. Brain2019; 142: 2492–2509.
54.
Rempel-ClowerNLBarbasH. The laminar pattern of connections between prefrontal and anterior temporal cortices in the rhesus monkey is related to cortical structure and function. Cereb Cortex2000; 10: 851–865.
55.
FletcherPCHensonRN. Frontal lobes and human memory: insights from functional neuroimaging. Brain2001; 124: 849–881.
56.
SchottBHNiklasCKaufmannJ, et al.Fiber density between rhinal cortex and activated ventrolateral prefrontal regions predicts episodic memory performance in humans. Proc Natl Acad Sci U S A2011; 108: 5408–5413.
57.
BarkerGRIWarburtonEC. Putting objects in context: a prefrontal-hippocampal-perirhinal cortex network. Brain Neurosci Adv2020; 4: 2398212820937621.
JobsonDDHaseYClarksonAN, et al.The role of the medial prefrontal cortex in cognition, ageing and dementia. Brain Commun2021; 3: fcab125.
60.
GradyCLMcIntoshARBeigS, et al.Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci2003; 23: 986–993.
61.
HorwitzBMcIntoshARHaxbyJV, et al.Network analysis of PET-mapped visual pathways in Alzheimer type dementia. Neuroreport1995; 6: 2287–2292.
62.
PeiJZhangCZhangX, et al.Low-intensity transcranial ultrasound stimulation improves memory in vascular dementia by enhancing neuronal activity and promoting spine formation. Neuroimage2024; 291: 120584.
63.
HuangXLinZWangK, et al.Transcranial low-intensity pulsed ultrasound modulates structural and functional synaptic plasticity in rat hippocampus. IEEE Trans Ultrason Ferroelectr Freq Control2019; 66: 930–938.
64.
RezaiARD'HaesePFFinomoreV, et al.Ultrasound blood-brain barrier opening and aducanumab in Alzheimer's disease. N Engl J Med2024; 390: 55–62.
65.
GuoYDangGHordacreB, et al.Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex modulates electroencephalographic functional connectivity in Alzheimer's disease. Front Aging Neurosci2021; 13: 679585.
